List of insiders holdings for INCYTE CORP:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
1 | Baker Brothers Life Sciences Capital (GP) LLC BAKER JULIAN BAKER FELIX Director 10% Owner | 2017-02-22 16:47:01 | 34,389,438 0 | 34,389,438 | Form 13D |
2 | BAKER BIOTECH CAPITAL II GP LLC BAKER FELIX BAKER JULIAN 10% Owner | 2017-02-22 16:47:01 | 34,389,438 0 | 34,389,438 | Form 13D |
3 | Baker Bros. Capital (GP) LLC BAKER JULIAN BAKER FELIX Director 10% Owner | 2017-02-22 16:47:01 | 34,389,438 0 | 34,389,438 | Form 13D |
4 | 14159 capital (GP) LLC BAKER JULIAN BAKER FELIX Director 10% Owner | 2017-02-22 16:47:01 | 34,389,438 0 | 34,389,438 | Form 13D |
5 | Baker / Tisch Capital (GP) LLC BAKER JULIAN BAKER FELIX Director 10% Owner | 2017-02-22 16:47:01 | 34,389,438 0 | 34,389,438 | Form 13D |
6 | Baker Biotech Capital (GP) LLC BAKER JULIAN BAKER FELIX Director 10% Owner | 2017-02-22 16:47:01 | 34,389,438 0 | 34,389,438 | Form 13D |
7 | BAKER BROS. ADVISORS LP 14159 L.P. 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner | 2024-06-14 18:23:05 | 31,209,896 0 | 31,209,896 | Form 13D |
8 | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner | 2025-06-12 16:29:40 | 559,963 28,238,931 | 28,798,894 | Form 4 |
9 | TISCH ANDREW H No longer 10% owner. | 2005-02-10 11:31:03 | 1,541,669 0 | 1,541,669 | Form 13G |
10 | TISCH THOMAS J No longer 10% owner. | 2004-08-13 15:58:35 | 117,592 1,416,661 | 1,534,253 | Form 4/A |
11 | TISCH JAMES S No longer 10% owner. | 2004-08-13 15:58:06 | 117,592 1,216,661 | 1,334,253 | Form 4/A |
12 | TISCH DANIEL R No longer 10% owner. | 2006-04-21 12:04:18 | 1,126,669 0 | 1,126,669 | Form 13G |
13 | WHITFIELD ROY A Director | 2014-01-17 16:19:51 | 662,832 0 | 662,832 | Form 5 |
14 | Hoppenot Herve Chairman / CEO | 2025-04-03 16:49:22 | 563,573 0 | 563,573 | Form 4 |
15 | FRIEDMAN PAUL A Director | 2020-05-28 16:27:11 | 267,327 15,000 | 282,327 | Form 4 |
16 | BROOKE PAUL A Director | 2020-04-02 17:01:14 | 221,911 40,000 | 261,911 | Form 4 |
17 | HASTINGS DAVID C Chief Financial Officer | 2014-06-06 18:47:53 | 227,470 0 | 227,470 | Form 4 |
18 | Stamoulis Christiana EVP & Chief Financial Officer | 2025-04-03 16:50:59 | 129,093 0 | 129,093 | Form 4 |
19 | Stein Steven H EVP & Chief Medical Officer | 2025-04-03 16:50:25 | 125,132 0 | 125,132 | Form 4 |
20 | Wenqing Yao EVP, Head of Discovery Chem | 2021-07-07 17:54:42 | 113,629 0 | 113,629 | Form 4 |
21 | SWAIN PAULA J EVP, Human Resources | 2025-04-03 16:49:53 | 107,344 0 | 107,344 | Form 4 |
22 | Andrews Patricia S Chief Commercial Officer | 2012-01-23 16:43:17 | 100,000 0 | 100,000 | Form 4 |
23 | KELLER JOHN A Chief Business Officer | 2008-02-11 17:28:56 | 100,000 0 | 100,000 | Form 4 |
24 | DE SCHUTTER RICHARD U Chairman | 2015-03-09 16:35:21 | 99,821 0 | 99,821 | Form 4 |
25 | Pasquale Maria E EVP & General Counsel | 2023-07-18 16:00:15 | 89,999 0 | 89,999 | Form 4 |
26 | Morrissey Michael James EVP, Head of Tech. Operations | 2025-04-03 16:51:26 | 86,164 0 | 86,164 | Form 4 |
27 | SAXE JON S Director | 2004-04-01 14:08:05 | 80,000 0 | 80,000 | Form 4 |
28 | Dhanak Dashyant EVP & Chief Scientific Officer | 2023-07-18 16:00:18 | 75,864 0 | 75,864 | Form 4 |
29 | Daly James M EVP, Chief Commercial Officer | 2015-06-25 16:28:05 | 71,283 0 | 71,283 | Form 4 |
30 | METCALF BRIAN W Chief Drug Discovery Scientist | 2011-04-13 16:09:01 | 66,504 0 | 66,504 | Form 4 |
31 | Flannelly Barry P EVP & General Manager US | 2025-04-03 16:52:43 | 59,702 0 | 59,702 | Form 4 |
32 | Iyengar Vijay K EVP, GMAPPS | 2025-04-03 16:52:14 | 52,799 0 | 52,799 | Form 4 |
33 | Issa Mohamed Khairie EVP, Head of US Oncology | 2025-01-08 16:11:08 | 48,671 0 | 48,671 | Form 4 |
34 | ARIKO BARRY A Director | 2015-03-13 16:28:02 | 45,834 0 | 45,834 | Form 4 |
35 | Denton Sheila A. EVP & General Counsel | 2025-06-05 16:04:33 | 43,261 0 | 43,261 | Form 4 |
36 | CAGNONI PABLO J President, R&D | 2025-01-22 16:07:22 | 40,289 0 | 40,289 | Form 4 |
37 | HURLEY SCOTT W VP/Corp Controller & Treasurer | 2005-01-27 12:58:59 | 40,000 0 | 40,000 | Form 4 |
38 | Dickinson Jonathan Elliott EVP, General Manager, Europe | 2024-09-16 13:24:17 | 36,390 0 | 36,390 | Form 4 |
39 | Huber Reid M EVP, Chief Scientific Officer | 2018-07-18 16:28:26 | 34,571 0 | 34,571 | Form 4 |
40 | FBB Associates Director 10% Owner | 2012-06-18 17:33:56 | 33,410 0 | 33,410 | Form 3 |
41 | Heeson Lee EVP, Head of Incyte Intl | 2025-02-03 16:32:39 | 32,778 0 | 32,778 | Form 4 |
42 | Clancy Paul J Director | 2025-06-12 16:29:06 | 31,805 0 | 31,805 | Form 4 |
43 | BIENAIME JEAN JACQUES Director | 2025-06-12 16:30:12 | 30,057 0 | 30,057 | Form 4 |
44 | HARRIGAN EDMUND Director | 2025-06-12 16:28:00 | 29,168 0 | 29,168 | Form 4 |
45 | FOUSE JACQUALYN A Director | 2025-06-12 16:30:47 | 28,542 0 | 28,542 | Form 4 |
46 | High Katherine A Director | 2025-06-12 16:29:41 | 22,557 0 | 22,557 | Form 4 |
47 | SCHRECK PATRICIA A EVP, General Counsel | 2011-05-11 16:17:53 | 22,276 0 | 22,276 | Form 4 |
48 | Tray Thomas Principal Accounting Officer | 2025-06-03 16:00:53 | 22,003 0 | 22,003 | Form 4 |
49 | Siegel Eric H. EVP, General Counsel | 2017-09-15 16:28:33 | 21,053 0 | 21,053 | Form 4 |
50 | BRAWLEY OTIS W Director | 2025-06-12 16:31:17 | 20,468 0 | 20,468 | Form 4 |
51 | NIBLACK JOHN F Director | 2011-05-23 16:38:41 | 20,000 0 | 20,000 | Form 4 |
52 | Emmens Matthew Director | 2008-05-22 16:32:43 | 20,000 0 | 20,000 | Form 4 |
53 | CRAVES FRED B Director | 2005-06-03 09:43:51 | 20,000 0 | 20,000 | Form 4 |
54 | Levy Richard S EVP, Chief Drug Dev Officer | 2016-01-08 16:37:56 | 19,802 0 | 19,802 | Form 4 |
55 | DIXON WENDY L Director | 2022-04-04 16:00:32 | 17,768 0 | 17,768 | Form 4 |
56 | Schaffert Susanne Director | 2025-06-12 16:28:33 | 16,605 0 | 16,605 | Form 4 |
57 | Chardonnet Laurent Vice President and Treasurer | 2015-04-01 16:27:38 | 15,129 0 | 15,129 | Form 4 |
58 | FBB2 LLC Director 10% Owner | 2012-06-18 17:35:48 | 15,110 0 | 15,110 | Form 3 |
59 | Friedman Steven M. EVP, Biology & Preclinical Dev | 2010-05-20 16:11:55 | 15,000 0 | 15,000 | Form 4 |
60 | GRYSKA DAVID W Executive Vice President, CFO | 2018-07-18 16:12:41 | 10,235 0 | 10,235 | Form 4 |
61 | Trotta Matteo EVP, GM, Dermatology US | 2025-03-27 17:05:11 | 9,937 0 | 9,937 | Form 4 |
62 | Trower Paul Principal Accounting Officer | 2022-01-21 16:37:50 | 3,250 0 | 3,250 | Form 4 |
63 | PLATINUM ASSET MANAGEMENT LTD 10% Owner | 2009-02-10 18:56:09 | 0 0 | 0 | Form 13G |
64 | DAMIAL FOUNDATION INC 10% Owner | 2004-02-13 19:51:28 | 0 0 | 0 | Form 4 |
65 | TISCH BONNIE J 10% Owner | 2004-01-16 16:57:59 | 0 0 | 0 | Form 4 |